One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

ImmunityBio's stock has risen sharply this year. Read more on whether investors should look closely at shares or avoid the ...

MIT researchers discovered that the first vaccine dose primes the immune system for a stronger response to the second dose, ...

In the ongoing research, the team compared various dosing schedules and found that a two-dose strategy — administering 20 per ...

It is not making major news headlines like in the ‘80s, but HIV remains a significant health concern. In 2021, 1.9 million ...

MIT researchers have developed a new HIV vaccination method that generates a strong immune response with just two doses, one ...

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.

A new study highlights the role of natural killer T cells in influencing the immune response to dengue virus, potentially reducing the severity of subsequent infections.

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

Georgetown University Medical Center (GUMC) seminar highlighted research on a revolutionary approach to cancer treatment: ...

HIV stigma, for the first time in five years, is on the decline in the United States, despite knowledge gaps in certain ...

This year's recipients have been recognised for their work on the HIV epidemic, GLP-1-based drugs, and how DNA can stimulate ...